Journal
ENDOCRINE PATHOLOGY
Volume 29, Issue 2, Pages 137-149Publisher
HUMANA PRESS INC
DOI: 10.1007/s12022-018-9525-8
Keywords
Immunohistochemistry; SF-1; CYP11B2; CYP11B1; IGF-2; Ki67; p53; Beta-catenin; Mitotane; Adrenal cortical carcinoma
Categories
Funding
- Grants-in-Aid for Scientific Research [15H04711] Funding Source: KAKEN
Ask authors/readers for more resources
Careful morphological evaluation forms the basis of the workup of an adrenal cortical neoplasm. However, the adoption of immunohistochemical biomarkers has added tremendous value to enhance diagnostic accuracy. The authors provide a brief review of immunohistochemical biomarkers that have been used in the confirmation of adrenal cortical origin and in the detection of the source of functional adrenal cortical proliferations, as well as diagnostic, predictive, and prognostic biomarkers of adrenal cortical carcinoma. In addition, a brief section on potential novel theranostic biomarkers in the prediction of treatment response to mitotane and other relevant chemotherapeutic agents is also provided. In the era of precision and personalized medical practice, adoption of combined morphology and immunohistochemistry provides a new approach to the diagnostic workup of adrenal cortical neoplasms, reflecting the evolution of clinical responsibility of pathologists.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available